cd5l promot m2 macrophag polar autophagy-medi upregul id3 march 2018 | volum 9 | articl 4801 origin research publish : 12 march 2018 doi : 10.3389/fimmu.2018.00480 frontier immunolog | www.frontiersin.org edit : liwu li , virginia tech , unit state review : charl e. mccall , wake forest baptist medic center , unit state joan clria , hospit clnic de barcelona , spain *correspond : maria-rosa sarria mrsarria @ igtp.cat specialti section : articl submit molecular innat immun , section journal frontier immunolog receiv : 09 januari 2018 accept : 23 februari 2018 publish : 12 march 2018 citat : sanjurjo l , aran g , tllez  , amzaga n , armengol c , lpez , prat c sarria m-r ( 2018 ) cd5l promot m2 macrophag polar autophagy- mediat upregul id3 .
front .
immunol .
9:480. doi : 10.3389/fimmu.2018.00480 cd5l promot m2 macrophag polar autophagy- mediat upregul id3 luca sanjurjo1,2 , gemma aran1 , rica tllez1 , nria amzaga1 , carolina armengol3,4 , daniel lpez5 , clara prats5 maria-rosa sarrias1,3* 1 innat immun group , german tria pujol health scienc research institut ( igtp ) , barcelona , spain , 2 network biomed research diabet associ metabol disord ( ciberdem ) , barcelona , spain , 3 network biomed research hepat digest diseas ( ciberehd ) , barcelona , spain , 4 childhood liver oncolog group , program predict person medicin cancer ( pmpcc ) , german tria pujol health scienc research institut ( igtp ) , badalona , spain , 5 departa de fsica , escola superior  agricultura de barcelona , universitat politcnica de catalunya  barcelonatech castelldefel , barcelona , spain cd5l ( cd5 molecule-lik ) secret glycoprotein control key mechan inflammatori respons , involv process infect , atherosclero- sis , cancer .
macrophag , cd5l promot anti-inflammatori cytokin profil respons tlr activ .
present studi , question whether cd5l abl influenc human macrophag plastic , drive polar toward specif phenotyp .
compar cd5l-induc phenotyp function chang caus ifn/lp , il4 , il10 human monocyt .
phenotyp marker quantifi rt-qpcr flow cytometri , mathemat algorithm built analysi .
moreov , compar ros product , phagocyt capac , inflammatori respons lps .
cd5l drove cell toward polar similar induc il10 .
furthermor , il10- cd5l-treat macrophag show increas lc3-ii content coloc acid compart , therebi point enhanc autophagy-depend process .
accord , sirna target atg7 thp1 cell block cd5l-induc cd163 mer tyrosin kinas mrna efferocytosi .
cell , gene express profil valid indic upregul transcript factor id3 cd5l atg7 .
agreement , id3 silenc revers polar cd5l .
data point signific contribut cd5l-mediat autophagi induct id3 provid first evid cd5l drive macrophag polar .
keyword : cd5l , autophagi , macrophag polar , scaveng receptor cystein rich , mathemat algorithm , id3 , phagocytosi , efferocytosi introduct macrophag innat immun cell present vertebr tissu .
ensur homeostasi , cell respond intern extern cue exert trophic , regulatori , repair , effector func- tion ( 1 ) .
howev , also involv pathogenesi major human diseas , rang infect , atherosclerosi , chronic inflammatori diseas includ arthriti diabet , degen condit alzheim  diseas , cancer ( 2 ) .
http : //www.frontiersin.org/immunology/ http : //crossmark.crossref.org/dialog/ ? doi=10.3389/fimmu.2018.00480 & domain=pdf & date_stamp=2018-03-12 http : //www.frontiersin.org/immunology/arch http : //www.frontiersin.org/immunology/editorialboard http : //www.frontiersin.org/immunology/editorialboard https : //doi.org/10.3389/fimmu.2018.00480 http : //www.frontiersin.org/immunology/ http : //www.frontiersin.org https : //creativecommons.org/licenses/by/4.0/ mailto : mrsarria @ igtp.cat https : //doi.org/10.3389/fimmu.2018.00480 https : //www.frontiersin.org/journal/10.3389/fimmu.2018.00480/ful https : //www.frontiersin.org/journal/10.3389/fimmu.2018.00480/ful https : //www.frontiersin.org/journal/10.3389/fimmu.2018.00480/ful http : //loop.frontiersin.org/people/514575 http : //loop.frontiersin.org/people/531676 http : //loop.frontiersin.org/people/229928 http : //loop.frontiersin.org/people/229925 http : //loop.frontiersin.org/people/514206 2 sanjurjo et al .
cd5l drive m2 macrophag polar frontier immunolog | www.frontiersin.org march 2018 | volum 9 | articl 480 function divers macrophag attribut abil alter phenotyp respons chang microenviron ( 3 ) .
plastic allow acquir wide rang function , proinflammatori , pathogen- elimin , subsequ tissue-damag ( refer m1 classic activ macrophag ) anti-inflammatori , immunosuppress , wound-heal ( refer m2 altern activ ) ( 4 ) .
context given inher- ent plastic cell , grow interest appli knowledg polar treat human diseas .
regard , repolar macrophag might offer attract therapeut approach diseas cancer ( 5 ) .
various subpopul polar macrophag defin basi vitro stimul .
m1 prototyp macrophag induc th1 inflammatori cytokin , microbi factor , combin two .
turn , m2 subset compris macrophag induc exposur th2 cytokin il4 il13 , immun complex combin il1 lps , glucocorticoid , anti-inflammatori cytokin il10 tgf , tumor microenvironment factor il6 leukemia inhibitor factor ( 6 , 7 ) .
, adopt macrophag nomenclatur propos murray et al .
base activ stimulus , i.e. , m-inf/lp , m-il4 , m-il10 , well m-dexamethason ( dxm ) , also refer m1 , m2a , m2c , respect ( 8 ) .
mac- rophag subset classifi basi gene signatur , activ signal pathway , surfac molecul express pattern , secretori profil , function properti ( 6 , 7 , 912 ) .
howev , regard , studi perform murin model .
although model led great advanc , show import discrep human .
moreov , inform regard human macrophag polar limit scatter , especi regard function character .
observ thus highlight urgent need advanc knowledg human macrophag polar ( 5 ) .
macrophag main sourc cd5-like protein ( cd5l ) , 40-kda solubl glycoprotein belong scaveng receptor cystein rich superfamili ( 13 ) .
cd5l involv broad spectrum biolog function ( 14 ) .
various mous model diseas support notion cd5l particip pathogenesi inflammatori process , includ cancer , prevent apoptosi macrophag cell type ( 1520 ) .
human cd5l also shown modul aspect macrophag biolog , name anti-microbi respons mycobacterium tuberculosi ( 21 ) tlr activ increas autophag mechan ( 22 , 23 ) .
moreov , cd5l contribut atherogenesi promot oxldl uptak macrophage-endotheli cell adhes ( 24 ) .
cd5l circul serum relat high amount ( 25 ) , result proteom profil highlight putat serum biomark inflammatori condit atop dermat ( 26 ) , kawasaki diseas well liver cirrhosi ( 2729 ) .
signific alter plasma cd5l level , togeth report control macrophag respons , consist suggest function role protein host inflammatori reaction .
like mani key modul macrophag activ , cd5l express tight regul cell tissu ( 20 , 30 , 31 ) , upregul inflammatori condit also dur- ing cardiovascular metabol patholog .
likewis , vitro cultur macrophag express cd5l unless previous activ specif stimuli ( 19 , 24 , 32 ) .
, studi involv cd5l human mac- rophag polar .
end , perform comprehens analysi human macrophag polar vitro .
use novel mathemat algorithm analyz phenotyp chang , togeth function studi , reveal first time thatlik il10cd5l drive macrophag toward m2 phenotyp .
addit , cd5l express restrict macrophag treat il10 .
furthermor , result provid first evi- denc cd5l involv m2 macrophag polar depend autophag mechan id3 transcript factor .
materi method primari cell cell line studi involv human sampl conduct follow declar helsinki principl current legisl confidenti person data approv human ethic committe hospit universitari german tria pujol .
buffi coat , provid blood tissu bank ( barcelona , spain ) , obtain healthi blood donor follow institut standard oper procedur blood donat process , includ inform consent .
cd3+ cell deplet rosettesep human cd3 deplet cocktail ( stemcel technolog ) .
peripher blood mononuclear cell ( pbmc ) isol describ previous ( 23 ) ficoll-paqu ( ge healthcar ) densiti gradient centrifug 400  g 25 min .
recov cell wash twice pbs count use perfect-count microspher ( cytogno ) , follow manufactur  instruct .
peripher blood monocyt ( pb monocyt ) isol adher 5 % co2 incub 37c rpmi-1640 2 mm glutamin ( lonza ) supplement 10 % heat-inactiv human ab serum ( sigma-aldrich ) 30 min .
non-adher cell remov adher cell wash twice pbs incub rpmi-1640 2 mm glutamin , 10 % heat-inactiv fetal bovin serum ( fbs , lonza ) , 100 u/ml penicillin , 100 g/ml streptomycin ( sigma- aldrich ) 24 h prior experi .
percentag adher cd14+ cell ( pb monocyt ) routin obtain 94.98 % ( 3.26 % ) .
phagocytosi assay , pb monocyt differenti incub rpmi 10 % heat-inactiv fbs 7 day prior experi , describ previous ( 24 ) .
stabli transfect thp1-vector thp1-cd5l cell line generat describ amzaga et al .
( 24 ) .
cell grown cultur medium ( rpmi-1640 2 mm glutamin , 100 u/ ml penicillin , 100 g/ml streptomycin ) supplement 10 % heat-inactiv fbs 250 g/ml geneticin ( gibco ) .
prior experi , cell differenti macrophag incub 10 ng/ml phorbol 12-myrist 13-acet ( pma , sigma-aldrich ) cultur medium 24 h. http : //www.frontiersin.org/immunology/ http : //www.frontiersin.org http : //www.frontiersin.org/immunology/arch 3 sanjurjo et al .
cd5l drive m2 macrophag polar frontier immunolog | www.frontiersin.org march 2018 | volum 9 | articl 480 wash pbs grown cultur medium 24 h. cell refer thp1 .
hepg2 cell purchas atcc ( american type cultur collect ) cul- ture emem supplement 2 mm glutamin ( lonza ) , 100 u/ml penicillin , 100 g/ml streptomycin , 10 % heat- inactiv fbs .
vitro polar macrophag pb monocyt thp1 macrophag polar incub indic time 50 ng/ml ifn ( preprotech ) plus 100 ng/ml lps escherichia coli o111 : b4 ( sigma-aldrich ) ( inf/lp ) , 40 ng/ml il4 ( preprotech ) , 50 ng/ ml il10 ( preprotech ) , 40 ng/ml dxm ( kern pharma ) .
control popul incub cultur medium (  ) without polar cytokin .
assess effect human cd5l ( homo sapien cd5l , hscd5l ) pb monocyt , cell incub 1 g/ml albumin ( alb ) purifi human plasma ( grifol ) , use control protein , 1 g/ml endotoxin-fre recombin cd5l ( rcd5l ) express chines hamster ovari cell , detail ref .
( 24 ) .
posit control cd5l mrna upregul , cell treat 1 m t1317 ( tocri bioscienc , bristol , uk ) , plus 1 m 9cra ( sigma-aldrich ) .
multicolor flow cytometri analysi pb monocyt ( 106 cells/wel ) plate six-wel plate incub 72 h polar stimuli final concentr 5 % fbs .
detach accutas ( sigma-aldrich ) , wash pbs , incub 100 l block buffer [ pbs contain 10 % human ab serum ( sigma- aldrich ) , 2 % fcs ( lonza ) , 0.02 % nan3 ( sigma-aldrich ) ] .
cell label brilliant stain buffer ( bd bioscienc ) combin fluoresc conjug monoclon antibodi hladr , cd80 , cd23 , cd206 , cd163 ( bd bioscienc ) .
flow cytometri analysi perform bd lsrfortessa instrument use facsdiva softwar ( bd bioscienc ) , 10,000 event acquir sampl .
integr median fluoresc intens ( imfi ) comput multipli relat frequenc ( percentag posit ) cell express marker median fluoresc intens ( mfi ) cell popul .
algorithm develop classif polar macrophag basi phenotyp respons ifn/lp , il4 , il10 donor ( = 1:26 ) , defin vector includ imfi measur five surfac marker certain stimulus st ( st = ifn/lp , il4 , il10 ) imfid , st = ( ) imfi imfi imfi imfi imfihladr cd80 cd23 cd206 cd163 , , , , dd , st ( 1 ) mean respons sampl specif stimulus calcul written correspond vector .
therefor , stimulus obtain one mean vector , contain five mean valu imfi measur , one surfac marker .
imfimean , st = { } { } ( mean imfi mean imfi mean imfi hladr cd80 cd , , , , 223 cd2016 cd163 stmean imfi mean imfi , , , , , { } { } { } ) ( 2 ) given ( ) presenc surfac marker mem- brane result fluoresc intens scale may differ marker ( ii ) sought simpli determin tendenc surfac marker increas decreas certain stimulus , defin normal scale imfi marker , thus obtain normal imfi , imfi .
carri normal , took maximum refer- enc valu surfac marker aris five mean vector , imfimean , st .
normal appli individu measur valu ( i.e. , donor , stimulus , surfac marker ) follow , fix 1 valu exceed : imfi min imfi max imfi sm sm sm , mean , st ifn lps il4 il  , , / , d= { } = 11 sm hladr , cd80 , cd23 , cd206 , cd163 0 1 ; ;         = ( 3 ) normal algorithm also appli mean vector , thus obtain dimensionless mean vector use respons pattern stimuli , imfi pattern , st , shown figur 1b .
imfi pattern , st   = imfi , imfi , imfihladr , mean cd80 , mean cd ( 223 , mean cd206 , mean cd163 , mean st , imfi , imfi  ) .
( 4 ) respons pattern use classifi sampl respons given stimulus .
hypothes sampl stimul ifn/lp show lowest distanc ifn/lp pattern ( ) imfi pattern , ifn / lps respons also compar il4 pattern ( ) imfi pattern , il4 il10 pattern ( ) imfi pattern , il10 .
let us assum sampl certain donor , , treat stimulus st ( st = ifn/lp , il4 , il10 ) .
sampl experiment analyz surfac marker determin .
normal concentra- tion surfac marker evalu vector imfi st , d   = imfi , imfi , imfi , imfhladr , cd80 , cd23 , ( ii , imficd206 , cd163 , st   ) .
magnitud set compar three pattern use three geometr distanc vector , name diststifn/lp , , diststil4 , , diststil10 , , follow : distst ifn/lp =  , imfi imfit , pattern , ifn / lps   ( 5 ) distst il = 4 , imfi imfist , pattern , il4   ( 6 ) distst il = 10 , imfi imfist , pattern , il10   ( 7 ) sampl classifi basi minimum distanc , i.e. , sampl stimul ifn/lp , expect min dist dist dist distst ifn lps st il st il st if    { } =/ , , , , , d4 10 nn/lps , .
http : //www.frontiersin.org/immunology/ http : //www.frontiersin.org http : //www.frontiersin.org/immunology/arch 4 sanjurjo et al .
cd5l drive m2 macrophag polar frontier immunolog | www.frontiersin.org march 2018 | volum 9 | articl 480 figur 1 | continu http : //www.frontiersin.org/immunology/ http : //www.frontiersin.org http : //www.frontiersin.org/immunology/arch tabl 1 | algorithm classifi sampl n treat unknown stimulus .
( 1 ) experiment determin imfi n vector stimul sampl ( n ) mean flow cytometri , includ measur five surfac marker ( imfi , imfi , imfi , imfi , imfihladr .
cd80 .
cd23 .
cd206 .
cd16n n n n 33.n ) ( eq .
1 ) .
( 2 ) evalu normal concentr vector , imfi n , normal factor given eq .
3 .
( 3 ) evalu geometr distanc imfi n pattern vector ( , , ) imfi imfi imfipattern , ifn/lp pattern , il4 pattern , il10   ( eq 57 ) .
( 4 ) classif sampl accord minimum distanc criterion : min dist dist distifn/lp il4 iln n n   { } , , 10 .
figur 1 | cd5l induc phenotyp macrophag like il10 .
( ) multicolor flow cytometri analysi hladr , cd80 , cd23 , cd206 , cd163 marker profil pb monocyt treat 72 h medium alon (  ) , standard polar stimuli ( inf/lp , il4 , il10 ) , recombin cd5l ( cd5l ) , albumin ( alb ) human serum .
graph show integr median fluoresc intens ( imfi ) valu maker .
data 28 12 blood donor standard stimuli rcd5l/alb includ , respect .
( b ) normal profil .
mean respons pattern monocyt stimuli , repres normal vector imfi pattern , st ( st = , ifn/lp , il4 , il10 , cd5l ) .
standard stimuli : n = 26 , rcd5l/alb n = 12 .
( c ) distanc sampl respons normal profil .
blue : distanc ifn/lp pattern ( diststifn/lp , ) ; orang : distanc il4 pattern ( diststil4 , ) ; green : distanc il10 pattern ( diststil10 , ) .
sampl 12 blood donor stimul ifn/lp , il4 , il10 , cd5l includ .
( ) pb monocyt treat 24 h , amount mrna encod cd80 , tnf , cd206 , tgm2 , cd163 , mer tyrosin kinas ( mertk ) , cd36 , vascular endotheli growth factor ( vegf ) measur rt-qpcr .
data show mean least four blood donor .
( e ) thp1 macrophag incub indic stimuli 24 h , amount mrna encod cd80 , tgm2 , cd163 , mertk measur rt-qpcr .
data show mean least three independ experi .
( f ) western blot imag pb monocyt incub 24 h human albumin ( alb ) , rcd5l il10 ( left ) , thp1-vector , thp1-cd5l macrophag ( right ) probe specif antibodi phosphoryl stat3 ( tyr705 ) , stat3 , tubb2a .
repres blot three independ experi .
( , , e ) , data present mean  sem .
*p  0.05 ; **p  0.01 ; ***p  0.001 student  t-test , vs. macrophag cultur medium alon (  ) column .
tabl 2 | list primer use studi .
gene forward primer ( 5  3 ) revers primer ( 5  3 ) cd80 ctgcctgacctactgctttg ggcgtacactttcccttctc tnf gaggaggcgctccccaagaag gtgaggagcacatgggtggag tgm2 cctcgtggagccagttatcaa gtctgggatctccaccgtcttc cd206 acacaaactgggggaaaggtt tcaaggaagggtcggatcg cd163 caccagttctcttggaggaaca tttcacttccactctcccgc mertk ctctggcgtagagctatcact aggctgggttggtgaaaaca cd36 gagaactgttatggggctat ttcaactggagaggcaaagg vegf agggcagaatcatcacgaagt agggtctcgattggatggca cd5l gacgagaagcaacccttcag cccagagcagaggttgtctc atg7 atgatccctgtaacttagccca cacggaagcaaacaacttcaac bex1 aggcccaggagtaatggagt aaccgcctacgatttcctct id3 gagaggcactcagcttagcc tccttttgtcgttggacatgac gapdh tcttcttttgcgtcgccag agccccagccttctcca 5 sanjurjo et al .
cd5l drive m2 macrophag polar frontier immunolog | www.frontiersin.org march 2018 | volum 9 | articl 480 procedur appli assess distanc respons cell cd5l three pattern ( distcd5lifn/lp , , distcd5lil4 , , distcd5lil10 , ) , normal- ize imficd5l , d obtain mean eq .
3 ( = 1:12 ) .
valu distanc shown figur 1c .
complet algorithm classifi stimul sampl summar tabl 1. rna extract quantit rt-pcr pb monocyt thp1 macrophag ( 1  106 cells/wel ) incub 24 h rpmi medium contain 5 % fcs polar stimuli .
cell wash pbs disrupt qiazol lysi reagent ( qiagen ) , rna extract use mirneasi mini kit ( qiagen ) .
total rna ( 1 g ) revers transcrib use rna cdna ecodri premix ( clontech ) .
rt reaction amplifi lightcycl 480 pcr system ( roch ) use kapa sybr fast master mix ( kapa biosystem ) .
sampl incub initi denatur 95c 5 min , 40 pcr cycl perform use follow condit : 95c 10 , 60c 20 , 72c 10 s. primer pair use studi list tabl 2 .
gene express valu normal express level gapdh ( glyceraldehyd 3-phosphat dehydrogenas ) .
fold induct level calcul use express level gene untreat condit (  ) refer .
measur cytokin secret pb monocyt ( 105 cells/wel ) incub 72 h polar stimuli dilut cultur medium contain 5 % fcs subsequ stimul lps ( e. coli 0111 : b4 , sigma-aldrich ) .
4 h ( tnf ) 24 h ( il1 il6 ) , cultur supernat fraction collect assay cytokin product opteia elisa , follow manufactur  instruct ( bd bioscienc ) .
experi use thp1 macrophag treat sirna target id3 express , cell sirna-transfect allow dif- ferenti ( see ) .
stimul lps ( 5  104 cells/wel ) assay cytokin product .
color develop ad 3,3,5,5-tetramethylbenzidin liquid substrat ( sigma-aldrich ) .
optic densiti read 450 nm varioskan flash micropl reader ( thermofish scientif inc. ) .
ros measur pb monocyt ( 105 cells/wel ) polar indic stimuli 72 h load 10 m dichloro-dihydro- fluorescein diacet ( h2-dcf-da ) ( sigma-aldrich ) pbs 30 min 37c dark .
wash twice resuspend 100 l pbs .
absorb 485 nm meas- ure use varioskan flash micropl reader ( thermofish scientif inc. ) .
intracellular ros level calcul use level control cell (  ) refer .
analysi phagocytosi flow cytometri 2.5  105 pb monocyt thp1 macrophag plate 24-well plate , polar 72 h incub 3 m http : //www.frontiersin.org/immunology/ http : //www.frontiersin.org http : //www.frontiersin.org/immunology/arch 6 sanjurjo et al .
cd5l drive m2 macrophag polar frontier immunolog | www.frontiersin.org march 2018 | volum 9 | articl 480 yg fluoresbrit microspher ( polysci ) , e. coli k-12 , staphylococcus aureus fluoresc bioparticl ( molecular probe ) indic ratio ( macrophag : microsphere/bacteria ) 1 h 37 4c .
incub 4c perform measur extracellular attach rather intern , sinc uptak occur temperatur .
cell harvest 20-min incub accutas ( sigma-aldrich ) .
extens wash cold pbs fix pbs con- tain 4 % paraformaldehyd ( panreac ) 30 min .
phagocytosi quantifi flow cytometri facscantoii instrument ( bd bioscienc ) use facsdiva softwar ( bd bioscienc ) .
induct apoptosi efferocytosi assay 1  106 hepg2 cell plate six-wel plate label 5 m celltrac cfse ( invitrogen ) pbs 20 min 37c 5 % co2 .
wash medium replac emem 10 % fbs .
twenty-four hour later , apoptosi induc 45 min uv irradi follow 1 h rest 37c .
3,3  -dihexyloxacarbocyanin iodid ( dioc , sigma-aldrich ) propidium iodid ( pi ; sigma-aldrich ) use measur apoptosi flow cytometri , obtain 16.2 %  8.1 % live cell ( dioc+ , pi ) , 9.4 %  5.0 % earli apoptot cell ( dioc , pi ) , 68.3 %  5.2 % late apoptot cell necrot cell ( pi+ ) .
efferocytosi assay perform co-cultur thp1 cell pre-label , 0.5 m celltrack deep red dye ( thermo fisher ) , cfse-label apoptot hepg2 cell 1 h indic ratio ( macrophag : apoptot cell ) 37 4c .
cell harvest 20-min incub accutas ( sigma-aldrich ) , extens wash cold pbs , fix .
flow cytometri perform facscantoii instru- ment .
facsdiva softwar use quantifi percentag deep red-label macrophag phagocytos cfse-label apoptot cell .
addit , efferocytosi observ fluo- rescent microscopi use axio observ z1 duo lsm 710 confoc system ( carl zeiss microscopi gmbh ) .
western blot analysi cell lysat stat3 phosphoryl , lc3 convers id3 detect analysi , pb monocyt thp1 macrophag ( 1  106 cells/wel ) plate six-wel plate polar incub indic stimuli 37c indic period .
wash cold tbs lyse tbs lysi buffer [ 20 mm tris , ph 7.5 , contain 150 mm nacl , 1 mm edta , 1 mm egta , 1 % triton x-100 , 1 mm na3vo4 , 1 mm pmsf , complet proteas inhibitor cocktail ( sigma-aldrich ) ] 30 min 4c .
stat3 lc3 , nuclei cell debri remov cen- trifug 8,000  g 15 min , id3 , total cell lysat resolv .
protein concentr measur bca protein assay reagent kit ( thermo fisher scientif ) , follow manufactur  instruct .
end , 4050 g protein cell lysat resolv 10 % sds-polyacrylamid gel ( 12 % lc3 ) reduc condit electrophoret transfer nitrocellulos membran ( bio-rad laboratori ) .
block start block tbs buffer ( thermo fisher ) 1 h room temperatur incub overnight 4c mab anti-phosphoryl stat3 tyr705 ( clone 9e12 , 05-485 , millipor ) , poab anti-stat3 ( 06-596 , millipor ) , poab anti-lc3 ( nb1002220 , novus biolog ) , mab anti-id3 ( 9837 , cell signal technolog ) dilut block buffer .
blot also probe beta-tubulin ( mab anti-tubb2a , t9026 , sigma-aldrich ) histon h3 ( poab anti-hist3h3 , 9715 , cell signal technolog ) determin equal load .
membran subsequ incub 60 min room temperatur appropri fluoresc coupl secondari antibodi ( irdye680cw-conjug goat anti- rabbit igg irdy 800cw-conjug goat anti-mous igg , li-cor bioscienc , 92632,221 92632,210 , respect ) dilut block buffer .
three 15-min wash step perform tbs-0.01 % tween 20 ( merck millipor ) .
bound antibodi detect odyssey infrar imag ( li-cor ) , densitometr analysi perform use odyssey v.3 softwar ( li-cor ) .
fluoresc microscopi studi pb monocyt ( 105 cells/wel ) plate incub indic stimuli 72 h millicel ez slide ( merck millipor ) .
cell fix pbs contain 4 % paraform- aldehyd ( panreac ) incub 24 h 4c moab anti-cd5l ( abnova ) poab anti-lc3 ( novus biolog ) pbs contain 0.3 % triton x-100 10 % human ab serum ( sigma-aldrich ) .
cell subsequ incub 1 h room temperatur alexa fluor 488 f ( ab  ) 2 fragment goat anti-mous igg alexa fluor 647 f ( ab  ) 2 fragment goat anti- rabbit igg ( molecular probe ) pbs contain 0.3 % triton x-100 .
step , unbound antibodi remov three wash pbs .
final , nuclei stain 10 min room temperatur pbs contain 800 nm hoechst 33,258 solut ( sigma-aldrich ) .
cell wash three time pbs , coverslip mount fluoromount media ( sigma-aldrich ) left 4c overnight .
determin autophag flux , cultur medium replac prewarm rpmi contain 100 nm lysotrack red ( molecular probe ) , cell incub 37c 1 h fixat .
slide examin axio observ z1 duo lsm 710 con- focal system analyz zen black softwar ( carl zeiss microscopi gmbh ) .
lc3 lc3-lysotrack red coloc puncta per cell determin use green red puncta coloc macro imagej softwar threshold imag size 3 30 pixel2 puncta circular 0.81 , describ previous ( 23 ) .
silenc cd5l , atg7 , id3 express undifferenti thp1 cell transfect 10 nm set four sirna target cd5l , atg7 , id3 equal concentra- tion non-target negat control pool ( on-target plus sirna , dharmacon ) use interferin ( polyplus-transfect sa ) , previous describ ( 23 ) , follow manufactur  instruct .
24 h , medium replac , cell differenti 24 h cultur medium supplement 10 ng/ml pma .
next , medium replac cultur http : //www.frontiersin.org/immunology/ http : //www.frontiersin.org http : //www.frontiersin.org/immunology/arch 7 sanjurjo et al .
cd5l drive m2 macrophag polar frontier immunolog | www.frontiersin.org march 2018 | volum 9 | articl 480 medium 24 h test cd5l , atg7 , id3 express pcr western blot use function assay describ .
indic , cell treat 40 ng/ml dxm addit 24 h prior analysi .
gene express profil analysi total rna isol purifi 106 thp1-vector thp1-cd5l macrophag use trizol reagent ( invitrogen ) rneasi column ( qiagen ) .
crna generat 10 g total rna use superscript ( invitrogen ) messageamp ii-biotin ( ambion , usa ) rna transcription-label kit ( enzo biochem ) crna hybrid codelink human whole genom bioarray ( appli microarray ) 37c 16 h use traymix hybrid ( biotray , franc ) .
sampl label cy5 ( bionova ) , array scan innoscan 700 scanner ( innopsi ) .
data normal analysi perform bioconductor r , limma packag bio- informat platform ciberehd , spain .
microarray data deposit ncbi  gene express omnibus databas ( https : //www.ncbi.nlm.nih.gov/geo/ ) access number gse111315 .
list gene obtain microarray analysi associ biolog process annot , defin gene ontolog ( go ) consortium ( 18 ) .
david bioinformat resourc ( 19 , 20 ) use search statisti- calli signific enrich function categori .
statist analysi data present mean  sem least three experi .
student  t-test perform graphpad prism v.5 softwar .
valu p  0.05 consid signific .
result polar cd5l promot m2 phenotyp profil like induc il10 gain thorough understand role cd5l human macrophag polar , examin phenotyp also function chang induc protein , compar respons cultur medium (  ) standard polar stimuli ifn/lp , il4 , il10 .
neither human pb monocyt thp1 macrophag express detect level cd5l protein .
therefor , supplement pb monocyt cultur human rcd5l human alb control .
although latter inert protein , previous use negat control , observ signific effect pb monocyt assay .
hand , generat macrophag cell line stabli express human cd5l , refer thp1-cd5l ( 21 , 24 ) .
initi analysi includ combin flow cytometri stud- ie hladr , cd80 , cd206 , cd23 , cd163 polar marker pb monocyt healthi blood donor treat- ment medium alon , standard polar stimuli , rcd5l ( figur 1a ) .
experi , inf/lp select increas hladr cd80 diminish cd206 cd163 compar medium alon ; il4 increas hladr , cd80 , cd23 , cd206 inhibit cd163 ; il10 , well rcd5l , increas cd163 , reduc cd23 .
collect , flow cytometri data use build algorithm macrophag polar classif , thus facilit studi respons pattern unbias manner ( tabl 1 ) .
end , flow cytometri data marker express normal ( figur 1b ) .
donor , respons compar normal profil ifn/lp , il4 , il10 cal- culat distanc respons standard stimuli .
shortest distanc consid optim .
use  minimum distanc criterion ,  92 % sampl treat ifn/lp , il4 , il10 correct classifi accord appli stimuli ( ifn/lp , il4 , il10 ) ( figur 1c ) .
classif algorithm use compar distanc rcd5l-induc surfac marker level ( ) imficd5l , d three pattern standard stimuli ( ifn/lp , il4 , il10 ) .
criterion minimum distanc classifi 10 12 rcd5l-treat sampl ( 83 % ) il10-lik respons 2 ( 17 % ) ifn/lps-lik respons ( figur 1c , right ) .
therefor , accord algorithm , rcd5l promot phenotyp resembl il10 10 12 donor .
rt-qpcr reinforc find , show treatment pb monocyt rcd5l modifi cd80 , tnf , cd206 , tgm2 express induc predomin increas cd163 , mer tyrosin kinas ( mertk ) , cd36 , vascular endotheli growth factor ( vegf ) mrna express , similar way il10 ( figur 1d ) .
next analyz express select set gene thp1 macrophag found il10 modifi signific manner .
therefor , assay corticosteroid dxm addit m2-polar stimulus cell .
thp1 macrophag respond ifn/lp , il4 , dxm modul cd80 , tgm2 , cd163 , mertk gene express similar way pb monocyt ( figur 1e ) .
interest , thp1-cd5l mac- rophag show profil resembl thp1-vector macrophag treat il10 dxm .
given stat3 key transcript regul il10 ( 33 ) , assess activ .
western blot experi reveal increas stat3 phosphoryl ( tyr705 ) pb monocyt polar il10 rcd5l compar incu- bate control human alb ( figur 1f , left ) .
similar result observ stat3 phosphoryl unstimul thp1-cd5l vs. control thp1-vector macrophag ( figur 1f , right ) .
taken togeth , data reinforc notion cd5l molecular driver m2 macrophag polar .
data suggest thp1 macrophag suitabl purpos present studi .
cd5l drive macrophag m2 function phenotyp similar induc il10 next , perform seri function experi determin whether rcd5l-polar pb monocyt ( m-cd5l ) share m-il10 m-dxm effector mechan .
regard , like m-il10 , m-cd5l secret lower level inflammatori mediat tnf , il1 , il6 respons lps , therebi sug- gest decreas inflammatori respons molecul http : //www.frontiersin.org/immunology/ http : //www.frontiersin.org http : //www.frontiersin.org/immunology/arch https : //www.ncbi.nlm.nih.gov/geo/ figur 2 | cd5l , like il10 , promot anti-inflammatori apoptot cell pro-phagocyt function macrophag .
pb monocyt thp1 macrophag ( indic ) treat 72 h indic stimuli left untreat (  ) , follow function test perform .
( ) amount tnf , il1 , il6 measur elisa cultur supernat polar macrophag , stimul 10 ng/ml lps 4 h tnf , 24 h il1 il6 .
graph show mean  sem least four blood donor , perform triplic .
( b ) intracellular ros releas quantifi via chang dcf fluoresc .
mean  sem fold chang relat unstimul cell (  ) three independ experi perform triplic shown .
( c ) pb monocyt incub 3 m latex microspher ratio 1:5 ( pb monocyt : microspher ) , escherichia coli staphylococcus aureus bioparticl ratio 1:10 ( pb monocyt : bacteria ) 1 h indic temperatur .
percentag fitc-posit cell determin flow cytometri .
data show mean  sem six independ donor .
( ) pb monocyt polar 72 h indic stimuli , deep red-stain , incub cfse-stain apoptot hepg2 cell ratio 1:2 ( pb monocyt : apoptot cell ) 1 h indic temperatur .
percentag cfse-posit pb monocyt determin flow cytometri .
graph show mean  sem five independ experi .
( e ) fluoresc microscopi imag unstimul deep red-stain thp1-vector thp1-cd5l macrophag ( purpl ) co-cultur apoptot cfse-hepg2 cell ( green ) 1 h 37c .
data present mean  sem .
*p  0.05 ; **p  0.01 ; ***p  0.001 student  t-test , vs. macrophag cultur medium alon (  ) column .
8 sanjurjo et al .
cd5l drive m2 macrophag polar frontier immunolog | www.frontiersin.org march 2018 | volum 9 | articl 480 ( figur 2a ) .
addit , il10 treatment reduc inflammatori ros product .
interest , treatment rcd5l opposit effect , slight increas ros level macrophag ( figur 2b ) .
studi three addit function featur macrophag , name phagocytosi latex bead bacteria , well apoptot cell clearanc .
assay , percentag fitc-posit cell increas dose-depend manner experi perform 37c 4c ( figur s1 supplementari materi ) .
observ indic increas fluoresc due uptak rather adher cell surfac .
interest , unlik inhibitori effect ifn/lp , treatment il4 , il10 , rcd5l alter phagocytosi latex bead , gram-neg e. coli gram-posit s. aureus ( figur 2c ) .
contrari , analyz efferocyt abil rcd5l-polar macrophag observ respond increas phagocytosi apoptot hepg2 cell .
regard , rcd5l il10 treatment increas popul fitc-posit cell http : //www.frontiersin.org/immunology/ http : //www.frontiersin.org http : //www.frontiersin.org/immunology/arch figur 3 | cd5l express m2 macrophag .
( ) rt-qpcr analysi cd5l express primari macrophag ( left ) thp1 macrophag treat indic stimuli 24 h. data show mean valu least five blood donor five independ experi .
( b ) repres imag cd5l ( green ) primari macrophag treat indic stimuli 72 h. nuclei stain hoechst ( blue ) .
graph show cd5l mean fluoresc intens ( mfi )  sem 50 macrophag score random field .
( c ) analysi cd5l mrna level thp1-vector thp1-cd5l macrophag transfect sirna target cd5l ( cd5l ) non-target negat control ( ct ) 24 h treatment dexamethason ( dxm ) .
data show mean valu four independ experi .
( ) relat amount mrna encod cd80 , tgm2 , cd163 , mer tyrosin kinas ( mertk ) measur rt-qpcr cd5l-silenc ( cd5l ) non-target negat ct transfect thp1-cd5l macrophag 24 h dxm treatment .
data show mean  sem four independ experi .
data present mean  sem .
*p  0.05 ; **p  0.01 ; ***p  0.001 student  t-test .
9 sanjurjo et al .
cd5l drive m2 macrophag polar frontier immunolog | www.frontiersin.org march 2018 | volum 9 | articl 480 46 25 % , respect , compar macrophag treat control protein alb ( p = 0.008 p = 0.0011 student  t-test , respect ) ( figur 2d ) .
similar result obtain compar thp1-cd5l thp1-vector macrophag ( figur 2e ; figur s1 supplementari materi ) .
altogeth , data suggest cd5l drive macrophag anti-inflammatori high-efferocyt function phenotyp , like shown m2 , m-il10 .
cd5l express promot m2-polar stimuli determin express cd5l polar macrophag , analyz cd5l mrna protein pb monocyt polar inf/lp , il4 , il10 , dxm .
lxr/rxr synthet ligand ( t13+9cr ) use posit control cd5l upregula- tion , nuclear receptor induc cd5l express ( 19 , 34 ) .
rt-qpcr data show cd5l mrna level upregul 9.31- 5.54-fold il10 dxm polar , respect , compar medium alon ( figur 3a , left ) .
accord , dxm-treat thp1-vector macrophag show 5.53-fold upregul cd5l mrna ( figur 3a , right ) .
upregul cd5l gene express also associ increas protein express , observ immunofluo- rescenc stain confoc microscopi use anti-cd5l moab ( figur 3b ) .
studi particip cd5l acquisit m2 phenotyp , silenc express dxm-treat thp1-vector macrophag .
cd5l mrna induc- tion dxm cell abolish sirna transfect compar thp1-vector macrophag transfect control sirna ( figur 3c ) .
interest , abolit concomit diminish express m2 marker cd163 ( 56.8 % ) mertk ( 100 % ) ( figur 3d ) .
contrast , express m1 marker cd80 remain unalt , therebi sug- gest chang specif .
altogeth , data indic cd5l express m2 macrophag , reinforc notion cd5l contribut acquisit m2 phenotyp .
autophagi protein atg7 involv m-cd5l polar autophagi lc3-associ phagocytosi may involv macrophag polar ( 3539 ) .
cd5l induc autophagi ( 23 ) , next examin whether autophag machineri involv cd5l-driven macrophag polar .
autophagi vesicl format fusion lysosom examin m-ifn/lp , m-il4 , m-il10 , m-dxm m-cd5l ( figur 4a , b ) .
end , measur lc3 puncta per cell coloc lc3 puncta acid organell , http : //www.frontiersin.org/immunology/ http : //www.frontiersin.org http : //www.frontiersin.org/immunology/arch figur 4 | involv autophagi m-cd5l polar .
( ) 72-h treat pb monocyt stain specif lc3 antibodi ( green ) , acid organell lysotrack red ( purpl ) , nuclei hoechst dye ( blue ) .
left panel : repres confoc microscopi imag show lc3 lysotrack red stain coloc yellow ( merg ) .
right graph : mean  sem quantit data show number lc3 puncta per cell ( lc3+ puncta/cel ) lysotrack puncta per cell ( lt+ puncta/cel ) lc3-lysotrack red coloc puncta per cell ( lc3+ lt+ puncta/cel ) four blood donor , includ least 50 cell score random field .
( b ) immuno-blot lc3i ii level 72-h treat pb monocyt .
repres blot three independ experi .
detect tubb2a use measur equal load .
( c ) analysi atg7 mrna level thp1-vector thp1-cd5l macrophag , untreat (  ) transfect sirna target atg7 ( atg7 ) non-target negat control ( ct ) .
data show mean valu five independ experi .
( ) relat amount mrna encod cd80 , tgm2 , cd163 , mer tyrosin kinas ( mertk ) measur rt-qpcr untreat (  ) , atg7-silenc ( atg7 ) , non- target negat control ( ct ) transfect thp1-cd5l macrophag .
data show mean valu five independ experi .
( e ) determin degre efferocytosi thp1-cd5l macrophag , non-target negat control transfect cell ( ct ) , atg7-silenc cell co-cultur apoptot cfse-hepg2 cell 1 h indic temperatur ratio .
data show mean  sem percentag fitc-posit cell five independ experi , determin flow cytometri .
*p  0.05 ; **p  0.01 ; ***p  0.001 t-test ( , ce ) .
10 sanjurjo et al .
cd5l drive m2 macrophag polar frontier immunolog | www.frontiersin.org march 2018 | volum 9 | articl 480 http : //www.frontiersin.org/immunology/ http : //www.frontiersin.org http : //www.frontiersin.org/immunology/arch 11 sanjurjo et al .
cd5l drive m2 macrophag polar frontier immunolog | www.frontiersin.org march 2018 | volum 9 | articl 480 latter detect acidotrop fluoresc dye lysotrack red .
polar il10 , dxm , rcd5l triplic lc3 puncta per cell ( 2.40  0.24 , 2.87  0.29 , 2.21  0.47 , respect , vs. 0.66  0.19 ) promot lysotrack red coloc ( 0.57  0.17 , 0.41  0.16 , 0.36  0.12 doubl posit puncta per cell , respect , vs. 0.008  0.008 ) compar treat- ment control protein alb .
addit , cell exam- ine microtubule-associ protein 1 light chain 3a/b ( lc3 ) -ii status western blot total cell lysat ( figur 4b ) .
assay reveal , like il10 dxm , rcd5l-induc high lc3-ii level , therebi support notion increas autophagy-depend mechan .
next silenc express atg7 , integr com- ponent cellular autophag machineri , thp1-cd5l macrophag observ phenotyp function conse- quenc .
experi , sirna treatment led ~60 % silenc atg7 , previous report ( 23 ) ( figur 4c ) .
silenc atg7 inhibit cd163 mertk mrnas 55 100 % , respect , compar express level thp1-vector macrophag , affect express m1 marker cd80 tgm2 ( figur 4d ) .
moreov , atg7 silenc reduc efferocyt capac thp1-cd5l mac- rophag 68 % compar cell treat control non-target sirna use thp1-vector macrophag activ- iti refer ( figur 4e ) .
data suggest autophag mechan particip cd5l-induc m2 macrophag phenotyp function .
gene express profil analysi cd5l- express macrophag reveal id3 molecular target array-bas express profil experi perform compar thp1-vector thp1-cd5l macrophag .
express 16 9 gene upregul downregul , respect , cd5l express ( > 2-fold induct , p < 0.01 ) ( figur 5a ) .
list gene modifi cd5l ( > 2-fold , p < 0.05 ) subject go analysi .
use david bio- informat resourc show statist signific enrich sever function categori , includ leukocyt migrat , metabol process , signal transduct , apoptosi , among list gene modul cd5l ( figur 5b ) .
analyz express profil data identifi intracellular player cd5l-mediat macrophag polar select dna-bind protein inhibitor id3 ( id3 ) transcript factor brain express x-link 1 ( bex1 ) , up- downregul gene , respect ( fold chang vs. thp1-vector : id3 7.2 bex1 9.59 , p < 0.0001 ) .
accord , rt-qpcr analysi reveal upregul id3 downreg- ulat bex1 thp1-cd5l vs. thp1-vector macrophag ( figur 5c ) .
interest , bex1 mrna also downregul primari macrophag treatment ( i.e. , ifn/lp , il4 , il10 , rcd5l ) compar incub medium alon ( figur 5d , left ) .
therefor , data indi- cate specif involv bex1 il10- cd5l-driven polar .
contrast , id3 express downregul macrophag treat ifn/lp , upregul treat il10 rcd5l ( figur 5d , right ) .
confirm cd5l-depend id3 upregul protein level western blot thp1 macrophag lysat ( figur 5e , left ) , m-il10 m-cd5l ( figur 5e , right ) compar stimuli medium alon .
altogeth , data suggest cd5l il10 induc id3 express macrophag .
studi whether modul id3 express cd5l mediat induct autophagi ( figur 5f ) .
blockad atg7 express thp1-cd5l macrophag partial revers id3 mrna induct ( 56 % inhibit ) .
taken togeth , result indic id3 mrna upregul il10- cd5l-polar mac- rophag express regul , least part , autophagi .
id3 involv m-cd5l polar id3 transcript regul negat control basic helixloop-helix transcript factor form heterodim inhibit dna-bind transcript activ .
determin contribut id3 cd5l-mediat polariza- tion , silenc express thp1-cd5l macrophag sirna treatment .
observ ~91 % inhibit id3 mrna ( figur 6a , left ) reduct id3 protein level cell , level observ control cell ( thp1- vector ) ( figur 6a , right ) .
decreas id3 express modifi cd80 cd163 express , led 100 % decreas mertk mrna level , thus complet revers effect cd5l overexpress thp1 macrophag ( figur 6b ) .
accord decreas mertk express , id3 silenc abolish effect cd5l efferocyt activ cell 99 % ( figur 6c ) .
moreov , id3 silenc thp1-cd5l macrophag enhanc tnf il1 secret respons tlr induct , therebi revers modulatori effect cd5l cytokin secret respons lps ( figur 6d ) .
data strong support notion id3 transcript factor involv induct phenotyp function characterist m-cd5l .
discuss although macrophag polar character mice definit gene/protein signatur marker , secretori profil , activ pathway , definit macrophag polar state human still poor character .
, conduct comprehens phenotyp function profil human pb monocyt thp1 cell treat standard polar stimuli may use studi relat macrophag polar .
regard , prove util approach character macrophag respons cd5l .
specif , demonstr cd5l drive m2 macrophag polar similar manner il10 .
find relev m2 macrophag key regul inflammatori heal respons , well tumor progress .
identifi novel molecul mechan involv human macrophag polar may facilit discoveri novel diagnost therapeut tool .
http : //www.frontiersin.org/immunology/ http : //www.frontiersin.org http : //www.frontiersin.org/immunology/arch figur 5 | gene express profil analysi thp1-vector thp1-cd5l macrophag .
( ) global effect cd5l overexpress thp1 cell line .
thp1-vector ( n = 2 replic ) thp1-cd5l ( n = 3 replic ) .
heat-map gene up- downregul cd5l express ( > 2-fold induct , p < 0.05 ) .
posit ( orang ) negat ( green ) chang gene express control cell shown .
( b ) gene ontolog analysi list gene modul cd5l show signific enrich sever biolog process .
( c ) rt-qpcr analysi brain express x-link 1 ( bex1 ) id3 express thp1-vector thp1-cd5l macrophag .
data show mean valu six independ experi .
( ) rt-qpcr analysi bex1 id3 express pb monocyt incub indic stimuli 24 h. data show mean valu five blood donor .
( e ) western blot id3 thp1-vector thp1-cd5l cell ( left ) 72 h-polar pb monocyt ( right ) .
repres blot three independ experi .
detect hist3h3 use measur equal load .
( f ) level bex1 id3 mrna untreat (  ) non-target sirna negat control transfect cell ( ct ) atg7-silenc ( atg7 ) thp1 cell .
data show mean five independ experi .
*p  0.05 ; **p  0.01 ; ***p  0.001 student  t-test .
12 sanjurjo et al .
cd5l drive m2 macrophag polar frontier immunolog | www.frontiersin.org march 2018 | volum 9 | articl 480 polar studi , includ express data mathemat analysi 5 surfac marker pb mono- cyte 26 healthi donor , agre literatur .
addit , provid global pictur phenotyp chang polar .
accord , observ m1 m-inf/lp show upregul hladr conjunct http : //www.frontiersin.org/immunology/ http : //www.frontiersin.org http : //www.frontiersin.org/immunology/arch figur 6 | involv transcript factor id3 m-cd5l polar .
thp1 macrophag left untreat (  ) transfect sirna target id3 ( id3 ) non-target negat control ( ct ) , follow function test perform : ( ) rt-qpcr ( left ) western blot repres imag ( right ) id3 mrna protein silenc .
rt-qpcr data show mean five independ experi .
detect hist3h3 use measur equal load western blot experi .
( b ) amount mrna encod cd80 , cd163 , mer tyrosin kinas ( mertk ) measur rt-pcr .
data show mean five independ experi .
( c ) analysi phagocytosi apoptot hepg2 cell flow cytometri .
cfse-apoptot hepg2 cell co-cultur thp1 macrophag 1 h ratio 1:2 ( thp1 : apoptot cell ) .
graph show mean  sem five independ experi .
( ) amount tnf , il1 , il6 measur elisa cultur supernat 4 h ( tnf ) 24 h ( il1 il6 ) stimul 10 ng/ml lps .
graph show mean  sem four independ experi perform triplic .
*p  0.05 ; **p  0.01 , ***p  0.001 ; student  t-test .
13 sanjurjo et al .
cd5l drive m2 macrophag polar frontier immunolog | www.frontiersin.org march 2018 | volum 9 | articl 480 co-stimulatori molecul cd80 , may indica- tive increas antigen present ( 8 ) , downregul cd206 , molecul relat resolut inflamm ( 40 ) .
regard m2 macrophag , m-il4 enhanc hladr cd80 express , also cd206 cd23 , latter involv allerg reaction ( 41 ) .
surpris , il4 , like ifn/lp , induc downregul cd163 , wide accept marker m2 phenotyp ( 40 ) .
contrast , il10 , anoth m2 stimulus , upregul cd163 inhibit cd23 .
obtain global object valu phenotyp chang classifi macrophag polar basi specif treatment , develop mathemat algorithm .
marker , defin uniqu quantit descriptor , normal imfi magnitud , imfi .
magni- tude independ particular fluoresc scale dif- ferent marker assess .
therefor , imfi allow comparison effect ( up- downregul ) differ stimuli marker regardless relat amount fluoresc signal use .
quantifi distanc imfi five marker donor stimuli com- pare mean profil use vector .
approach , valid 92 % agreement , prove use classifi polar macrophag basi global phenotyp .
believ qualifi method excel tool classif purpos 8 % misclassif detect probabl relat inher heterogen human .
present algorithm allow us quantit determin cd5l-induc macrophag surfac marker express profil similar m-il10 profil .
howev , distanc valu given cd5l slight greater produc il10 , suggest two stimuli led global similar ident phenotyp respons .
summari , newli develop algorithm prove use determin effect differ stimuli macrophag polar .
phenotyp chang observ flow cytometri com- plement rt-qpcr data .
initi assay confirm chang cd80 , cd206 , cd163 mrna correl provid flow cytometri .
therefor , rt-qpcr use analysi follow addit subset-specif gene : tnf , one main inflammatori cytokin ; multifunc- tional enzym transglutaminas 2 , mertk , scaveng receptor cd36 , relat phagocytosi apoptot cell clearanc ( 40 ) ; vegf , involv angiogenesi ( 42 ) .
agreement previous find , cd5l modul gene similar way il10 .
http : //www.frontiersin.org/immunology/ http : //www.frontiersin.org http : //www.frontiersin.org/immunology/arch 14 sanjurjo et al .
cd5l drive m2 macrophag polar frontier immunolog | www.frontiersin.org march 2018 | volum 9 | articl 480 better understand effect polar treat- ment biolog function macrophag , next exam- ine function behavior cell .
accord literatur ( 7 ) , observ distinct secretori profil lps stimul .
m-inf/lp respond lps increas tnf , il1 , il6 express .
contrast , m-il10 also m-cd5l block inflamm , produc minim , basal level three cytokin respons lps .
although cd5l- il10-induc macrophag polar seem inhibit inflam- matori respons lps similar manner , data suggest effect cd5l caus direct induct il10 secret , sinc rcd5l effect il10 mrna protein level macrophag absenc tlr stimul ( 23 ) .
furthermor , anti-microbi respons involv ros product increas m-cd5l , contrast diminish level ros detect m-il10 ( 43 ) .
obser- vation thus reinforc idea cd5l act direct il10 induct .
phagocytosi pathogen , apoptot cell , cell debri key featur macrophag function host defens tissu homeostasi .
set phagocytosi experi use latex bead , bacteria , apoptot cell , observ suppress phagocyt activ m-inf/lp .
find line report show inf-treat macrophag show impair phagocyt activ ( 4446 ) .
convers , m-il10 m-cd5l show elev express uptak receptor cd163 , cd36 , mertk , well increas efferocytosi , observ consist find studi ( 47 ) reinforc role m2 macrophag resolut inflamm .
altogeth , phenotyp function data suggest cd5l drive macrophag polar toward anti-inflamma- tori pro-resolv phenotyp .
interest , vitro , cd5l express restrict il10- dxm-polar mac- rophag , therebi point posit feedback loop cd5l express mainten m2 phenotyp .
increas bodi evid show autophag machineri regul macrophag polar ( 3539 ) .
howev , discrep regard contribut autophagi m1 m2 polar ( 36 , 48 , 49 ) .
discrep may explain differ experiment set and/or background macrophag studi .
data show increas lc3 puncta lc3-lysotrack red-posit puncta per cell , well increas lc3-ii/-i ratio macrophag treat il10 , dxm , rcd5l , therebi sug- gest enhanc autophagi m2 macrophag .
addit analys protein particip autophagi signal- ing ( e.g. , p62/sqstm1 , mtor , ampk ) necessari determin key partner involv .
moreov , regard role autophagi cd5l polar , sirna experi target atg7 support notion , besid involv anti-inflammatori function ( 23 ) , autophagi play key role m2 marker express also clearanc apoptot cell m-cd5l .
identifi intracellular player involv cd5l-mediat polar , perform express profil experi compar thp1-vector thp1-cd5l macrophag .
thp1 cell line use show similar result primari cell regard marker express , stat3 activ , phagocytosi , efferocytosi .
list gene modul cd5l show statist signific enrich sever function categori , previous relat cd5l func- tion , includ leukocyt migrat , metabol process , signal transduct , apoptosi ( 14 ) , therebi valid data .
regard contribut id3 macrophag polariza- tion , posit feedback id3 m2 polar propos , id3 upregul m2-polar stimuli , name tgf ( 50 ) , lung cancer-condit medium , galectin-1 ( 51 ) .
data line result , cd5l il10 , also m2 driver , enhanc id3 expres- sion .
accord , blockad experi support notion id3 involv anti-inflammatori function clearanc apoptot cell m-cd5l macrophag .
interest , autophag flux block atg7 silenc thp1-cd5l cell , id3 upregul partial revers , thus suggest upregul id3 autophagy-depend .
best knowledg , first studi establish link id3 transcript factor autophagi .
summari , report comprehens method analyz human macrophag polar .
approach reveal novel role cd5l driver m2 macrophag polar upregul id3 autophag mechan .
result point cd5l potenti target futur therapi seek alter macrophag polar state .
could appli set cancer , reprogram tumor-associ macrophag promis mode treatment .
ethic statement studi involv human sampl conduct follow declar helsinki principl current legisl confidenti person data approv human ethic committe hospit universitari german tria pujol .
author contribut ls , ga , et , na perform experi .
ls , ga , m-rs design experi .
ls m-rs wrote manuscript .
ls , ga , m-rs , ca analyz data .
dl cp develop mathemat algorithm .
author read , discuss , agre final version manuscript .
acknowledg acknowledg annabel f. valledor ( nuclear receptor group , univers barcelona ) help discuss .
thank also go marco fernndez , gerard requena , pilar armengol ( flow cytometri microscopi unit , igtp ) , elisabet pedrosa ( for- mer genet platform , igtp ) , juanjo lozano ( bioinformat platform , ciberehd ) , marta valeri ( microscopi platform , vall  hebron research institut ) technic help .
http : //www.frontiersin.org/immunology/ http : //www.frontiersin.org http : //www.frontiersin.org/immunology/arch 15 sanjurjo et al .
cd5l drive m2 macrophag polar frontier immunolog | www.frontiersin.org march 2018 | volum 9 | articl 480 fund work support grant fundaci la marat de tv3 ( mtv3 2013-3610 ) also instituto de salud carlo iii ( isciii ) , erdf ( fis ip10/01565 , ip13/1906 , ip16/0974 , fis ip13/02340 m-rs ca , respect ) .
et receiv scholarship igtp .
m-rs ca support agaur 2017-sgr-490 , miguel servet ( cpii14/00021 ) , ramn cajal ( ryc-2010-07249 ) program , respect .
igtp member cerca network institut .
supplementari materi supplementari materi articl found onlin http : //www.frontiersin.org/articles/10.3389/fimmu.2018.00480/ full # supplementary-materi .
refer 1 .
gordon , plddemann a. tissu macrophag : heterogen function .
bmc biol ( 2017 ) 15:53. doi:10.1186/s12915-017-0392-4 2 .
wynn ta , chawla , pollard jw .
macrophag biolog develop , homeostasi diseas .
natur ( 2013 ) 496:44555 .
doi:10.1038/nature12034 3 .
stout rd , jiang c , matta b , tietzel , watkin sk , suttl j. macrophag sequen- tialli chang function phenotyp respons chang microen- vironment influenc .
j immunol ( 2005 ) 175:3429 .
doi:10.4049/jimmunol .
175.1.342 4 .
mill cd .
m1 m2 macrophag : oracl health diseas .
crit rev immunol ( 2012 ) 32:46388 .
doi:10.1615/critrevimmunol.v32.i6.10 5 .
schultz jl .
reprogram macrophagesnew opportun therapeut target .
curr opin pharmacol ( 2016 ) 26:105 .
doi:10.1016/j .
coph.2015.09.007 6 .
edward jp , zhang x , frauwirth ka , mosser dm .
biochem function character three activ macrophag popul .
j leukoc biol ( 2006 ) 80:1298307 .
doi:10.1189/jlb.0406249 7 .
martinez fo , gordon s. m1 m2 paradigm macrophag activ : time reassess .
f1000prime rep ( 2014 ) 6:13. doi:10.12703/p6-13 8 .
murray pj , allen je , biswa sk , fisher ea , gilroy dw , goerdt , et al .
macrophag activ polar : nomenclatur experiment guidelin .
immun ( 2014 ) 41:1420 .
doi:10.1016/j.immuni.2014.06.008 9 .
jablonski ka , amici sa , webb lm , ruiz-rosado jdd , popovich pg , partida- sanchez , et al .
novel marker delin murin m1 m2 macrophag .
plos one ( 2015 ) 10 : e0145342 .
doi:10.1371/journal.pone.0145342 10 .
zhou , huang c , lin z , zhan , kong l , fang c , et al .
macrophag polariza- tion function emphasi evolv role coordin regula- tion cellular signal pathway .
cell signal ( 2014 ) 26:1927 .
doi:10.1016/j .
cellsig.2013.11.004 11 .
galvn-pea ,  neill laj .
metabol reprogram macrophag polariza- tion .
front immunol ( 2014 ) 5:420. doi:10.3389/fimmu.2014.00420 12 .
ivashkiv lb .
epigenet regul macrophag polar function .
trend immunol ( 2013 ) 34:21623 .
doi:10.1016/j.it.2012.11.001 13 .
gebe ja , kiener pa , ring hz , li x , franck u , aruffo a. molecular clone , map human chromosom 1 q21-q23 , cell bind characterist spalpha , new member scaveng receptor cysteine-rich ( srcr ) famili protein .
j biol chem ( 1997 ) 272:61518 .
doi:10.1074/jbc.272.10.6151 14 .
sanjurjo l , aran g , roher n , valledor af , sarria m-r. aim/cd5l : key protein control immun homeostasi inflammatori diseas .
j leukoc biol ( 2015 ) 98:17384 .
doi:10.1189/jlb.3ru0215-074r 15 .
qu p , du h , li , yan c. myeloid-specif express api6/aim/sp alpha induc system inflamm adenocarcinoma lung .
j immunol ( 2009 ) 182:164859 .
doi:10.4049/jimmunol.182.3.1648 16 .
zou , garifulin , berland r , boyartchuk vl .
listeria monocytogen infec- tion induc prosurviv metabol signal macrophag .
infect immun ( 2011 ) 79:152635 .
doi:10.1128/iai.01195-10 17 .
haruta , kato , hashimoto e , minjar c , kennedi , uto h , et al .
associ aim , novel apoptosi inhibitori factor , hepat via support mac- rophag surviv enhanc phagocytot function macrophag .
j biol chem ( 2001 ) 276:229104 .
doi:10.1074/jbc.m100324200 18 .
arai , shelton jm , chen , bradley mn , castrillo , bookout al , et al .
role apoptosi inhibitori factor aim/sp/api6 atherosclerosi develop .
cell metab ( 2005 ) 1:20113 .
doi:10.1016/j.cmet.2005.02.002 19 .
joseph sb , bradley mn , castrillo , bruhn kw , mak pa , pei l , et al .
lxr- depend gene express import macrophag surviv innat immun respons .
cell ( 2004 ) 119:299309 .
doi:10.1016/j.cell.2004.09.032 20 .
li , qu p , wu l , li b , du h , yan c. api6/aim/sp { alpha } /cd5l overexpress alveolar type ii epitheli cell induc spontan lung adenocarcinoma .
cancer res ( 2011 ) 71:548899 .
doi:10.1158/0008-5472.can-10-4225 21 .
sanjurjo l , amzaga n , vilaplana c , ccere n , marzo e , valeri , et al .
scaveng protein apoptosi inhibitor macrophag ( aim ) poten- tiat antimicrobi respons mycobacterium tuberculosi enhanc autophagi .
plos one ( 2013 ) 8 : e79670 .
doi:10.1371/journal.pon .
0079670 22 .
sarria m-r , rosel , snchez-barbero f , sierra jm , vila j , ylamo j , et al .
role human sp alpha pattern recognit receptor .
j biol chem ( 2005 ) 280:353918 .
doi:10.1074/jbc.m505042200 23 .
sanjurjo l , amzaga n , aran g , naranjo-gmez , aria l , armengol c , et al .
human cd5l/aim-cd36 axi : novel autophagi induc macrophag modul inflammatori respons .
autophagi ( 2015 ) 11:487502 .
doi:10.1080/15548627.2015.1017183 24 .
amzaga n , sanjurjo l , julv j , aran g , perez-cabeza b , bastos-amador p , et al .
human scaveng protein aim increas foam cell format cd36- mediat oxldl uptak .
j leukoc biol ( 2014 ) 95:50920 .
doi:10.1189/jlb .
1212660 25 .
sarria mr , padilla , monreal , carrasc , abian j , vive j , et al .
biochem character recombin circul human spalpha .
tissu antigen ( 2004 ) 63:33544 .
doi:10.1111/j.0001-2815.2004.00193.x 26 .
kk , hwang h-r , hk , phil yl , yu ji , ryu h-i , et al .
glycoproteom analysi plasma patient atop dermat : cd5l apo potenti biomark .
exp mol med ( 2008 ) 40:67785 .
doi:10.3858/emm .
2008.40.6.677 27 .
gangadharan b , antrobus r , dwek ra , zitzmann n. novel serum bio- marker candid liver fibrosi hepat c patient .
clin chem ( 2007 ) 53:17929 .
doi:10.1373/clinchem.2007.089144 28 .
mera k , uto h , mawatari , ido , yoshimin , nosaki , et al .
serum level apoptosi inhibitor macrophag associ hepat fibrosi patient chronic hepat c. bmc gastroenterol ( 2014 ) 14:27. doi:10.1186/1471-230x-14-27 29 .
gray j , chattopadhyay , beal gs , patman gl , miel l , king bp , et al .
proteom strategi identifi novel serum biomark liver cirrhosi hepatocellular cancer individu fatti liver diseas .
bmc cancer ( 2009 ) 9:271. doi:10.1186/1471-2407-9-271 30 .
iannaccon , hollingsworth tj , koirala , new dd , lenchik ni , beranova- giorgianni , et al .
retin pigment epithelium microglia express cd5 antigen-lik protein , novel autoantigen age-rel macular degener .
exp eye res ( 2017 ) 155:6474 .
doi:10.1016/j.exer.2016.12.006 31 .
wang c , yosef n , gaublomm j , wu c , lee , clish cb , et al .
cd5l/aim regul lipid biosynthesi restrain th17 cell pathogen .
cell ( 2015 ) 163:141327 .
doi:10.1016/j.cell.2015.10.068 32 .
miyazaki , hirokami , matsuhashi n , takatsuka h , naito m. increas suscept thymocyt apoptosi mice lack aim , novel murin macrophage-deriv solubl factor belong scaveng receptor cys- teine-rich domain superfamili .
j exp med ( 1999 ) 189:41322 .
doi:10.1084/ jem.189.2.413 33 .
yamaoka k , otsuka , niiro h , nakashima h , tanaka , nagano , et al .
select dna-bind activ interleukin-10-stimul stat mol- ecul human monocyt .
j interferon cytokin res ( 1999 ) 19:67985 .
doi:10.1089/107999099313839 34 .
valledor af , hsu l , ogawa , sawka-verhell , karin , glass ck .
activ liver x receptor retinoid x receptor prevent bacterial-induc mac- rophag apoptosi .
proc natl acad sci u ( 2004 ) 101:178138 .
doi:10.1073/ pnas.0407749101 http : //www.frontiersin.org/immunology/ http : //www.frontiersin.org http : //www.frontiersin.org/immunology/arch http : //www.frontiersin.org/articles/10.3389/fimmu.2018.00480/ful # supplementary-materi http : //www.frontiersin.org/articles/10.3389/fimmu.2018.00480/ful # supplementary-materi https : //doi.org/10.1186/s12915-017-0392-4 https : //doi.org/10.1038/nature12034 https : //doi.org/10.4049/jimmunol .
175.1.342 https : //doi.org/10.4049/jimmunol .
175.1.342 https : //doi.org/10.1615/critrevimmunol.v32.i6.10 https : //doi.org/10.1016/j.coph.2015.09.007 https : //doi.org/10.1016/j.coph.2015.09.007 https : //doi.org/10.1189/jlb.0406249 https : //doi.org/10.12703/p6-13 https : //doi.org/10.1016/j.immuni.2014.06.008 https : //doi.org/10.1371/journal.pone.0145342 https : //doi.org/10.1016/j.cellsig.2013.11.004 https : //doi.org/10.1016/j.cellsig.2013.11.004 https : //doi.org/10.3389/fimmu.2014.00420 https : //doi.org/10.1016/j.it.2012.11.001 https : //doi.org/10.1074/jbc.272.10.6151 https : //doi.org/10.1189/jlb.3ru0215-074r https : //doi.org/10.4049/jimmunol.182.3.1648 https : //doi.org/10.1128/iai.01195-10 https : //doi.org/10.1074/jbc.m100324200 https : //doi.org/10.1016/j.cmet.2005.02.002 https : //doi.org/10.1016/j.cell.2004.09.032 https : //doi.org/10.1158/0008-5472.can-10-4225 https : //doi.org/10.1371/journal.pone.0079670 https : //doi.org/10.1371/journal.pone.0079670 https : //doi.org/10.1074/jbc.m505042200 https : //doi.org/10.1080/15548627.2015.1017183 https : //doi.org/10.1189/jlb .
1212660 https : //doi.org/10.1189/jlb .
1212660 https : //doi.org/10.1111/j.0001-2815.2004.00193.x https : //doi.org/10.3858/emm.2008.40.6.677 https : //doi.org/10.3858/emm.2008.40.6.677 https : //doi.org/10.1373/clinchem.2007.089144 https : //doi.org/10.1186/1471-230x-14-27 https : //doi.org/10.1186/1471-2407-9-271 https : //doi.org/10.1016/j.exer.2016.12.006 https : //doi.org/10.1016/j.cell.2015.10.068 https : //doi.org/10.1084/jem.189.2.413 https : //doi.org/10.1084/jem.189.2.413 https : //doi.org/10.1089/107999099313839 https : //doi.org/10.1073/pnas.0407749101 https : //doi.org/10.1073/pnas.0407749101 16 sanjurjo et al .
cd5l drive m2 macrophag polar frontier immunolog | www.frontiersin.org march 2018 | volum 9 | articl 480 35 .
chen p , cescon , bonaldo p. autophagy-medi regul mac- rophag applic cancer .
autophagi ( 2014 ) 10:192200 .
doi:10.4161/auto.26927 36 .
yang , liu j , shao j , qin , ji q , zhang x , et al .
cathepsin s-mediat autophag flux tumor-associ macrophag acceler tumor develop promot m2 polar .
mol cancer ( 2014 ) 13:43. doi:10.1186/1476-4598-13-43 37 .
chang c-p , su y-c , hu c-w , lei h-i .
tlr2-depend select autophagi regul nf-b lysosom degrad hepatoma-deriv m2 mac- rophag differenti .
cell death differ ( 2013 ) 20:51523 .
doi:10.1038/ cdd.2012.146 38 .
liu k , zhao e , ilya g , lalazar g , lin , haseeb , et al .
impair macrophag autophagi increas immun respons obes mice promot proin- flammatori macrophag polar .
autophagi ( 2015 ) 11:27184 .
doi:10.10 80/15548627.2015.1009787 39 .
heckmann bl , boada-romero e , cunha ld , magn j , green dr. lc3- associ phagocytosi inflamm .
j mol biol ( 2017 ) 429:356176 .
doi:10.1016/j.jmb.2017.08.012 40 .
roszer t. understand mysteri m2 macrophag activ marker effector mechan .
mediat inflamm ( 2015 ) 2015:816460. doi:10.1155/2015/816460 41 .
vercelli , jabara h , lee b-w , woodland n , geha r , leung d. human recom- binant interleukin 4 induc fcer/cd23 normal human monocyt .
j exp med ( 1988 ) 167:140616 .
doi:10.1084/jem.167.4.1406 42 .
newman ac , hugh ccw .
macrophag angiogenesi : role wnt signal .
vasc cell ( 2012 ) 4:13. doi:10.1186/2045-824x-4-13 43 .
mill el ,  neill la .
reprogram mitochondri metabol mac- rophag anti-inflammatori signal .
eur j immunol ( 2016 ) 46:1321 .
doi:10.1002/eji.201445427 44 .
shepherd vl , cowan hb , abdolrasulnia r , vick s. dexamethason block interferon-gamma-medi downregul macrophag man- nose receptor .
arch biochem biophi ( 1994 ) 312:36774 .
doi:10.1006/abbi .
1994.1321 45 .
tariqu aa , logan j , thoma e , holt pg , sli pd , fantino e. phenotyp , function plastic featur classic altern activ human macrophag .
j respir cell mol biol ( 2015 ) 53:67688 .
doi:10.1165/ rcmb.2015-0012oc 46 .
wang z , zhou , sun c , lei , peng j , li w , et al .
interferon- inhibit non- opson phagocytosi macrophag via mtorc1-c/ebp pathway .
j innat immun ( 2015 ) 7:16576 .
doi:10.1159/000366421 47 .
korn , frasch sc , fernandez-boyanap r , henson pm , bratton dl .
modul macrophag efferocytosi inflamm .
front immunol ( 2011 ) 71:548899 .
doi:10.3389/fimmu.2011.00057 48 .
guo , lin c , xu p , wu , fu x , xia w , et al .
age induc autophagi impair cutan wound heal via stimul macrophag polar m1 diabet .
sci rep ( 2016 ) 6:36416. doi:10.1038/srep36416 49 .
chang cp , su yc , lee ph , lei hy .
target nfkb autophagi polar hepatoma-associ macrophag differenti .
autophagi ( 2013 ) 9:61921 .
doi:10.4161/auto.23546 50 .
gratchev , kzhyshkowska j , kannookadan , ochsenreit , popova , yu x , et al .
activ tgf-beta-specif multistep gene express program matur macrophag requir glucocorticoid-medi surfac express tgf-beta receptor ii .
j immunol ( 2008 ) 180:655365 .
doi:10.4049/jimmunol .
180.10.6553 51 .
kuo p-l , hung j-i , huang s-k , chou s-h , cheng d-e , jong y-j , et al .
lung cancer-deriv galectin-1 mediat dendrit cell anergi inhibitor dna bind 3/il-10 signal pathway .
j immunol ( 2011 ) 186:152130 .
doi:10.4049/jimmunol.1002940 conflict interest statement : author declar research con- duct absenc commerci financi relationship could constru potenti conflict interest .
copyright  2018 sanjurjo , aran , tllez , amzaga , armengol , lpez , prat sarria .
open-access articl distribut term creativ common attribut licens ( cc ) .
use , distribut reproduct forum permit , provid origin author ( ) copyright owner credit origin public journal cite , accord accept academ practic .
use , distribut reproduct permit compli term .
http : //www.frontiersin.org/immunology/ http : //www.frontiersin.org http : //www.frontiersin.org/immunology/arch https : //doi.org/10.4161/auto.26927 https : //doi.org/10.1186/1476-4598-13-43 https : //doi.org/10.1038/cdd.2012.146 https : //doi.org/10.1038/cdd.2012.146 https : //doi.org/10.1080/15548627.2015.1009787 https : //doi.org/10.1080/15548627.2015.1009787 https : //doi.org/10.1016/j.jmb.2017.08.012 https : //doi.org/10.1155/2015/816460 https : //doi.org/10.1084/jem.167.4.1406 https : //doi.org/10.1186/2045-824x-4-13 https : //doi.org/10.1002/eji.201445427 https : //doi.org/10.1006/abbi .
1994.1321 https : //doi.org/10.1006/abbi .
1994.1321 https : //doi.org/10.1165/rcmb.2015-0012oc https : //doi.org/10.1165/rcmb.2015-0012oc https : //doi.org/10.1159/000366421 https : //doi.org/10.3389/fimmu.2011.00057 https : //doi.org/10.1038/srep36416 https : //doi.org/10.4161/auto.23546 https : //doi.org/10.4049/jimmunol .
180.10.6553 https : //doi.org/10.4049/jimmunol .
180.10.6553 https : //doi.org/10.4049/jimmunol.1002940 http : //creativecommons.org/licenses/by/4.0/ http : //creativecommons.org/licenses/by/4.0/ cd5l promot m2 macrophag polar autophagy-medi upregul id3 introduct materi method primari cell cell line vitro polar macrophag multicolor flow cytometri analysi algorithm develop classif polar macrophag basi phenotyp respons ifn/lp , il4 , il10 rna extract quantit rt-pcr measur cytokin secret ros measur analysi phagocytosi flow cytometri induct apoptosi efferocytosi assay western blot analysi cell lysat fluoresc microscopi studi silenc cd5l , atg7 , id3 express gene express profil analysi statist analysi result polar cd5l promot m2 phenotyp profil like induc il10 cd5l drive macrophag m2 function phenotyp similar induc il10 cd5l express promot m2-polar stimuli autophagi protein atg7 involv m-cd5l polar gene express profil analysi cd5l-express macrophag reveal id3 molecular target id3 involv m-cd5l polar discuss ethic statement author contribut acknowledg fund supplementari materi refer
